Tuesday, August 25, 2026

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

Is Canada’s Shift to China a Sign of U.S. Isolation? Discover the Impact of Trump’s Tariffs

Biden's strategy post-Ukraine invasion contained Russia and checked China, while Trump's policies strained U.S. alliances and empowered China.

How Celltrion’s 30 Million KRW Donation and Dream Run 2026 Are Supporting Blood Cancer Patients

Celltrion donates 30 million KRW to support blood cancer patients, enhancing treatment quality and awareness through a charity run initiative.

Tag: epilepsy treatment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Brivaracetam vs. Levetiracetam: Which Epilepsy Drug Offers Better Safety and Efficacy?

Samjin Pharmaceutical launches Bricetam Tablets, improving epilepsy treatment with fewer side effects and better adherence for patients.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.